Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 21.2% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s share price shot up 21.2% during trading on Thursday . The company traded as high as C$0.21 and last traded at C$0.20. 292,294 shares were traded during mid-day trading, a decline of 46% from the average session volume of 538,273 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Price Performance

The firm has a market cap of C$27.89 million, a price-to-earnings ratio of -20.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The business has a 50 day simple moving average of C$0.10 and a 200-day simple moving average of C$0.07.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.